AU2002220533A1 - Dermal anti-inflammatory composition - Google Patents
Dermal anti-inflammatory compositionInfo
- Publication number
- AU2002220533A1 AU2002220533A1 AU2002220533A AU2053302A AU2002220533A1 AU 2002220533 A1 AU2002220533 A1 AU 2002220533A1 AU 2002220533 A AU2002220533 A AU 2002220533A AU 2053302 A AU2053302 A AU 2053302A AU 2002220533 A1 AU2002220533 A1 AU 2002220533A1
- Authority
- AU
- Australia
- Prior art keywords
- inflammatory composition
- dermal
- dermal anti
- inflammatory
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000003110 anti-inflammatory effect Effects 0.000 title 1
- 230000002500 effect on skin Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25188200P | 2000-12-08 | 2000-12-08 | |
| US60/251,882 | 2000-12-08 | ||
| PCT/DK2001/000813 WO2002045752A2 (en) | 2000-12-08 | 2001-12-07 | Dermal anti-inflammatory composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002220533A1 true AU2002220533A1 (en) | 2002-06-18 |
Family
ID=22953798
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002220533A Abandoned AU2002220533A1 (en) | 2000-12-08 | 2001-12-07 | Dermal anti-inflammatory composition |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20020165286A1 (en) |
| AU (1) | AU2002220533A1 (en) |
| WO (1) | WO2002045752A2 (en) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1423356A2 (en) * | 2001-08-28 | 2004-06-02 | Leo Pharma A/S | Novel aminobenzoephenones |
| US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
| PL377377A1 (en) * | 2002-12-20 | 2006-02-06 | Leo Pharma A/S | Novel aminobenzophenone compounds |
| JP4939216B2 (en) * | 2003-07-24 | 2012-05-23 | レオ ファーマ アクティーゼルスカブ | New aminobenzophenone compounds |
| US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
| WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
| CN101453982B (en) | 2006-05-30 | 2011-05-04 | 精达制药公司 | Two-Piece Internal Channel Osmotic Delivery System Flow Regulator |
| NZ593017A (en) | 2006-08-09 | 2011-08-26 | Intarcia Therapeutics Inc | Piston assembly for positioning lumen in an osmotic delivery system having groove to retain elastomeric O-ring |
| FR2910320B1 (en) * | 2006-12-21 | 2009-02-13 | Galderma Res & Dev S N C Snc | EMULSION COMPRISING AT LEAST ONE RETINOID AND BENZOLE PEROXIDE |
| FR2910321B1 (en) | 2006-12-21 | 2009-07-10 | Galderma Res & Dev S N C Snc | CREAM GEL COMPRISING AT LEAST ONE RETINOID AND BENZOLE PEROXIDE |
| US7488500B2 (en) * | 2007-02-16 | 2009-02-10 | Betty Bellman | Compositions and methods for alleviating skin disorders |
| US9011943B2 (en) * | 2007-02-16 | 2015-04-21 | Skin Evolution LLC | Compositions and methods for alleviating skin disorders |
| US7758901B2 (en) * | 2007-02-16 | 2010-07-20 | Betty Bellman | Compositions and methods for alleviating skin disorders |
| RU2440097C2 (en) | 2007-04-23 | 2012-01-20 | Интарсия Терапьютикс, Инк. | Method of treating insulin-independent diabetes and obesity, osmotic delivery system and method for making it |
| US20100273876A1 (en) * | 2007-05-31 | 2010-10-28 | Scott Seville | antibacterial formulation comprising a dialkyl sulphosuccinate and a carbanilide antibacterial agent |
| US8182826B2 (en) * | 2007-09-11 | 2012-05-22 | Whitmire A Jeffrey | Refreshment towel and applied solution |
| US10966431B2 (en) * | 2007-09-11 | 2021-04-06 | Freedom Towel Holdings, LLC. | Refreshment towel and applied solution |
| WO2009102467A2 (en) | 2008-02-13 | 2009-08-20 | Intarcia Therapeutics, Inc. | Devices, formulations, and methods for delivery of multiple beneficial agents |
| EP2206534A1 (en) | 2008-10-09 | 2010-07-14 | c-a-i-r biosciences GmbH | Dibenzocycloheptanone derivatives und pharmaceutical agents containing these compounds |
| SMT201700583T1 (en) | 2009-09-28 | 2018-01-11 | Intarcia Therapeutics Inc | Rapid establishment and/or termination of substantial steady-state drug delivery |
| US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
| US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
| JP6993235B2 (en) | 2015-06-03 | 2022-01-13 | インターシア セラピューティクス，インコーポレイティド | Implant installation and removal system |
| EP3733694A1 (en) | 2016-05-16 | 2020-11-04 | Intarcia Therapeutics, Inc | Glucagon-receptor selective polypeptides and methods of use thereof |
| USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
| USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
| CN106265511A (en) * | 2016-08-22 | 2017-01-04 | 江苏知原药业有限公司 | A kind of calcipotriol betamethasone self-micro emulsion formulation of excellent performance |
| JP7286542B2 (en) | 2017-01-03 | 2023-06-05 | インターシア セラピューティクス，インコーポレイティド | A method comprising continuous administration of a GLP-1 receptor agonist and co-administration of drugs |
| US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
| RS63581B1 (en) | 2017-10-05 | 2022-10-31 | Fulcrum Therapeutics Inc | P38 KINASE INHIBITORS REDUCE THE EXPRESSION OF DUX4 AND DOWNSTREAM GENES TO TREAT FSHD |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57171912A (en) * | 1981-04-14 | 1982-10-22 | Sumitomo Chem Co Ltd | Cream |
| IL101387A (en) * | 1992-03-26 | 1999-11-30 | Pharmos Ltd | Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets |
| US5314685A (en) * | 1992-05-11 | 1994-05-24 | Agouron Pharmaceuticals, Inc. | Anhydrous formulations for administering lipophilic agents |
| AT408067B (en) * | 1995-03-17 | 2001-08-27 | Gebro Pharma Gmbh | PHARMACEUTICAL COMPOSITION FOR TOPICAL APPLICATION AND METHOD FOR THE PRODUCTION THEREOF |
| GB9701453D0 (en) * | 1997-01-24 | 1997-03-12 | Leo Pharm Prod Ltd | Aminobenzophenones |
| SE9800729L (en) * | 1998-03-06 | 1999-09-07 | Scotia Lipidteknik Ab | New topical formulation I |
| RU2260422C2 (en) * | 1999-12-06 | 2005-09-20 | Лео Фарма А/С | AMINOBENZOPHENONES AS INHIBITORS IL-β AND TNF-α |
| US6531141B1 (en) * | 2000-03-07 | 2003-03-11 | Ortho-Mcneil Pharmaceutical, Inc. | Oil-in-water emulsion containing tretinoin |
| MXPA02011376A (en) * | 2000-05-22 | 2004-02-26 | Leo Pharma As | BENZOPHENONES AS INHIBITORS OF IL 1bgr; AND TNF agr;. |
-
2001
- 2001-12-06 US US10/003,709 patent/US20020165286A1/en not_active Abandoned
- 2001-12-07 WO PCT/DK2001/000813 patent/WO2002045752A2/en not_active Ceased
- 2001-12-07 AU AU2002220533A patent/AU2002220533A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002045752A2 (en) | 2002-06-13 |
| US20020165286A1 (en) | 2002-11-07 |
| WO2002045752A3 (en) | 2002-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002220533A1 (en) | Dermal anti-inflammatory composition | |
| AU2001282877A1 (en) | Cosmetic compositions | |
| AU2001292783A1 (en) | Antireflective composition | |
| AU3976200A (en) | Cosmetic compositions | |
| AU2001281887A1 (en) | Enamel composition | |
| AU2001265919A1 (en) | Cosmetic compositions | |
| AU4318000A (en) | Agarobiose-containing composition | |
| AU2001293728A1 (en) | Cosmetic composition | |
| AU1290501A (en) | Composition | |
| AU2001248215A1 (en) | Cosmetically active composition | |
| AU2002214324A1 (en) | Medicinal compositions | |
| AU2001290239A1 (en) | Medicinal composition | |
| AU7373000A (en) | Cosmetic compositions | |
| AU2001241098A1 (en) | Composition | |
| AU2176001A (en) | Cosmetic composition | |
| AU2002223761A1 (en) | Thickening composition | |
| AU2001275201A1 (en) | Acne-treating composition | |
| AU2001256202A1 (en) | Cosmetic compositions | |
| AU4085201A (en) | Pharmaceutical composition | |
| AU2001275219A1 (en) | Toothpaste composition | |
| AU2001287852A1 (en) | Composition | |
| AU2000274826A1 (en) | Cosmetic compositions | |
| AU2002212281A1 (en) | Anti-inflammatory active ingredients | |
| AU2001235764A1 (en) | Compositions | |
| AU5640500A (en) | Cosmetic compositions |